Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - galantamine hbr20.51 mg eqv galantamine base - capsule, coated, extended release - 16 mg - galantamine hbr20.51 mg eqv galantamine base 16 mg

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - galantamine hbr 30.76 mg eqv galantamine base - capsule, coated, extended release - 24 mg - galantamine hbr 30.76 mg eqv galantamine base 24 mg

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - galantamine hbr. 10.25 mg eqv galantamine base - capsule, coated, extended release - 8 mg - galantamine hbr. 10.25 mg eqv galantamine base 8 mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmaten international s.a. industrial park sapes - galantamine (galantamine hydrobromide) - capsules prolonged-release, hard - 8mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmaten international s.a. industrial park sapes - galantamine (galantamine hydrobromide) - capsules prolonged-release, hard - 16mg

Canada - English - Health Canada

mylan pharmaceuticals ulc - galantamine (galantamine hydrobromide) - capsule (extended release) - 16mg - galantamine (galantamine hydrobromide) 16mg - parasympathomemetic (cholinergic) agents

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 10.256 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; hydrogenated vegetable oil; povidone; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; polyvinyl acetate - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 30.768 mg - capsule, modified release - excipient ingredients: magnesium stearate; titanium dioxide; hydrogenated vegetable oil; gelatin; iron oxide red; brilliant blue fcf; povidone; sunset yellow fcf; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; sodium lauryl sulfate; polyvinyl acetate

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 20.512 mg - capsule, modified release - excipient ingredients: gelatin; allura red ac aluminium lake; hydrogenated vegetable oil; titanium dioxide; magnesium stearate; povidone; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; sodium lauryl sulfate; polyvinyl acetate

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 10.256 mg - capsule, modified release - excipient ingredients: gelatin; magnesium stearate; povidone; titanium dioxide; hydrogenated vegetable oil; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; sodium lauryl sulfate; polyvinyl acetate